Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Ivermectin × Clear all

Phase

Status

Terminated 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 1 Coronavirus Infections 1 COVID-19 1

Interventions

Cyclophosphamide 347 Carboplatin 293 pembrolizumab 275 Gemcitabine 275 Cisplatin 274 Radiotherapy 263 Paclitaxel 257 Docetaxel 251 Bevacizumab 217 Rituximab 204 Capecitabine 195 Nivolumab 186 Dexamethasone 176 Fluorouracil 172 fludarabine 159 Oxaliplatin 151 Doxorubicin 138 Leucovorin 128 Irinotecan 128 Pemetrexed 125 Etoposide 125 Cytarabine 122 fludarabine phosphate 113 Bortezomib 112 Lenalidomide 109 Filgrastim 108 Cetuximab 107 Erlotinib Hydrochloride 103 Temozolomide 98 Radiation 97

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04447235 2022-08-09

TITAN

Instituto do Cancer do Estado de São Paulo

Phase 2 Terminated

COVID-19, Neoplasms, Coronavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon ⚡